• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺静脉闭塞病的遗传病因。

Genetic cause of pulmonary veno-occlusive disease.

作者信息

Mohite Kaustubh, Sapare Anil Kumar

机构信息

Department of Pediatrics, Narayana Health City, Bengaluru, Karnataka, India.

出版信息

Lung India. 2022 Mar-Apr;39(2):191-194. doi: 10.4103/lungindia.lungindia_252_21.

DOI:10.4103/lungindia.lungindia_252_21
PMID:35259804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9053931/
Abstract

Pulmonary veno-occlusive disease (PVOD) is an important cause of pulmonary arterial hypertension (PAH) and is classified under idiopathic cause of PAH. Over a period of time, PVOD has been studied in detail in the western countries and various diagnostic criteria are formulated. Being a rapidly progressive disease, early diagnosis is of utmost importance which helps to initiate appropriate treatment. Recent studies suggest that PVOD has a genetic predisposition and has an autosomal recessive pattern of inheritance. Here, we discuss the case of siblings diagnosed with PVOD to have such genetic predisposition for this disease.

摘要

肺静脉闭塞性疾病(PVOD)是肺动脉高压(PAH)的一个重要病因,归类于特发性PAH。在过去一段时间里,西方国家对PVOD进行了详细研究并制定了各种诊断标准。作为一种快速进展性疾病,早期诊断至关重要,这有助于启动适当的治疗。最近的研究表明,PVOD具有遗传易感性,呈常染色体隐性遗传模式。在此,我们讨论一对被诊断为PVOD的兄弟姐妹具有该疾病遗传易感性的病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54fd/9053931/3e7ba8291673/LI-39-191-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54fd/9053931/3e7ba8291673/LI-39-191-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54fd/9053931/3e7ba8291673/LI-39-191-g001.jpg

相似文献

1
Genetic cause of pulmonary veno-occlusive disease.肺静脉闭塞病的遗传病因。
Lung India. 2022 Mar-Apr;39(2):191-194. doi: 10.4103/lungindia.lungindia_252_21.
2
Good response to pulmonary arterial hypertension-targeted therapy in 2 pulmonary veno-occlusive disease patients: A case report.2 例肺静脉闭塞病患者对肺动脉高压靶向治疗有良好反应:病例报告。
Medicine (Baltimore). 2021 Oct 15;100(41):e27334. doi: 10.1097/MD.0000000000027334.
3
Pulmonary veno-occlusive disease as a cause of severe pulmonary hypertension in a dog.肺静脉闭塞性疾病致犬重度肺动脉高压
Acta Vet Scand. 2018 Dec 5;60(1):78. doi: 10.1186/s13028-018-0433-1.
4
Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.遗传性和散发性肺静脉闭塞病的临床表型和结局:一项基于人群的研究。
Lancet Respir Med. 2017 Feb;5(2):125-134. doi: 10.1016/S2213-2600(16)30438-6. Epub 2017 Jan 11.
5
Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease.肺血管重构模式及普遍调控非抑制性 2(GCN2)在肺静脉闭塞病中的表达。
J Heart Lung Transplant. 2018 May;37(5):647-655. doi: 10.1016/j.healun.2017.09.022. Epub 2017 Oct 4.
6
Unique wreath-like smooth muscle proliferation of the pulmonary vasculature in pulmonary veno-occlusive disease versus pulmonary arterial hypertension.特发性肺血管环行平滑肌增生症与肺动脉高压肺静脉闭塞病的比较。
J Formos Med Assoc. 2020 Jan;119(1 Pt 2):300-309. doi: 10.1016/j.jfma.2019.05.019. Epub 2019 Jun 13.
7
Phenotypic Characterization of Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension.大量临床诊断为肺动脉高压患者队列中突变携带者的表型特征分析
Circulation. 2017 Nov 21;136(21):2022-2033. doi: 10.1161/CIRCULATIONAHA.117.028351. Epub 2017 Sep 28.
8
Diagnosis and management of pulmonary veno-occlusive disease.肺静脉闭塞病的诊断与管理
Expert Rev Respir Med. 2023 Jul-Dec;17(8):635-649. doi: 10.1080/17476348.2023.2247989. Epub 2023 Aug 21.
9
Case report: pulmonary veno-occlusive disease: a rare but fatal cause of pulmonary hypertension in a patient following allogeneic stem cell transplantation.病例报告:肺静脉闭塞病:异基因干细胞移植后患者肺动脉高压的一种罕见但致命的病因。
Acta Clin Belg. 2022 Jun;77(3):697-702. doi: 10.1080/17843286.2021.1945352. Epub 2021 Jun 30.
10
EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension.EIF2AK4 突变导致肺静脉闭塞性疾病,这是一种肺动脉高压的隐性形式。
Nat Genet. 2014 Jan;46(1):65-9. doi: 10.1038/ng.2844. Epub 2013 Dec 1.

本文引用的文献

1
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).2015年欧洲心脏病学会(ESC)/欧洲呼吸学会(ERS)肺动脉高压诊断和治疗指南:欧洲心脏病学会(ESC)和欧洲呼吸学会(ERS)肺动脉高压诊断和治疗联合工作组:得到以下组织认可:欧洲儿科和先天性心脏病协会(AEPC)、国际心肺移植学会(ISHLT)。
Eur Heart J. 2016 Jan 1;37(1):67-119. doi: 10.1093/eurheartj/ehv317. Epub 2015 Aug 29.
2
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).2015 ESC/ERS 肺动脉高压诊断与治疗指南:欧洲心脏病学会(ESC)和欧洲呼吸学会(ERS)肺动脉高压诊断与治疗工作组制定:该指南得到了欧洲儿科和先天性心脏病协会(AEPC)以及国际心肺移植学会(ISHLT)的认可。
Eur Respir J. 2015 Oct;46(4):903-75. doi: 10.1183/13993003.01032-2015. Epub 2015 Aug 29.
3
The amino acid sensor GCN2 inhibits inflammatory responses to apoptotic cells promoting tolerance and suppressing systemic autoimmunity.氨基酸传感器GCN2抑制对凋亡细胞的炎症反应,促进耐受性并抑制全身性自身免疫。
Proc Natl Acad Sci U S A. 2015 Aug 25;112(34):10774-9. doi: 10.1073/pnas.1504276112. Epub 2015 Aug 10.
4
Advances in therapeutic interventions for patients with pulmonary arterial hypertension.肺动脉高压患者治疗干预的进展
Circulation. 2014 Dec 9;130(24):2189-208. doi: 10.1161/CIRCULATIONAHA.114.006974.
5
Updated clinical classification of pulmonary hypertension.肺动脉高压的最新临床分类。
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D34-41. doi: 10.1016/j.jacc.2013.10.029.
6
EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension.EIF2AK4 突变导致肺静脉闭塞性疾病,这是一种肺动脉高压的隐性形式。
Nat Genet. 2014 Jan;46(1):65-9. doi: 10.1038/ng.2844. Epub 2013 Dec 1.
7
Pulmonary veno-occlusive disease.肺静脉闭塞病
Eur Respir J. 2009 Jan;33(1):189-200. doi: 10.1183/09031936.00090608.
8
Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology.肺静脉闭塞病:24例经组织学确诊病例的临床、功能、放射学及血流动力学特征与转归
Medicine (Baltimore). 2008 Jul;87(4):220-233. doi: 10.1097/MD.0b013e31818193bb.
9
From the Archives of the AFIP: pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.源自武装部队病理研究所档案:肺静脉闭塞性疾病与肺毛细血管瘤病
Radiographics. 2007 May-Jun;27(3):867-82. doi: 10.1148/rg.273065194.
10
Treatment of pulmonary arterial hypertension.肺动脉高压的治疗。
N Engl J Med. 2004 Sep 30;351(14):1425-36. doi: 10.1056/NEJMra040291.